A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo

NCT01813890 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Hallux Valgus

Interventions

DRUG: Tapentadol IR 50 mg
DRUG: Tapentadol IR 75 mg
DRUG: Placebo

Sponsor

Janssen-Cilag International NV

Collaborators

[object Object]